RespireRX
17 SlideShares
Personal Information
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.respirerx.com
Info
RespireRx Pharmaceuticals Inc. (formerly Cortex Pharmaceuticals, Inc.) is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression, and other brain-mediated breathing disorders.
Kontaktdetails
Tags
pennystock respirerx sleep apnea pharmaceutical investment biotechnology ampakine stocks biotech rspi cannabinoid obstructive sleep apnea dronabinol cannabis community biopharma osa investing finance opioid induced respiratory depression stock market pharma news oird business breathing disorder neurobiology cpap medical health timothy jones press release patent cbd stock tips investor drug development #biopharmaceutical $rspi cannabis spinal chord injury ampa receptors brain adhd sleep disorder bts18 biotech showcase breathing hypopnea science medicine quarterly
Mehr anzeigen

Präsentationen

(3)

RespireRx Pharmaceuticals Inc.: Phase 2A Clinical Trial of Ampakine CX1739 in the Prevention of OpioidInduced Respiratory Depression

Vor 6 Jahren • 82 Aufrufe

RespireRX: Biotech Showcase 2018 Slide Deck (PPT)

Vor 6 Jahren • 270 Aufrufe

RespireRx Corporate Slide Deck and Non Confidential Shortened Version

Vor 4 Jahren • 94 Aufrufe

Dokumente

(14)
Alle anzeigen

RespireRx Pharmaceuticals Inc. Announces Participation SLEEP 2017 in Boston, MA

Vor 6 Jahren • 16 Aufrufe

RespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap Conference

Vor 6 Jahren • 18 Aufrufe

Press Release: RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update

Vor 6 Jahren • 46 Aufrufe

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

Vor 6 Jahren • 15 Aufrufe

RespireRx Pharmaceuticals Inc. Announces Publication of Phase 2B PACE Study: Once per Night Treatment with Dronabinol Provides Statistically Significant Improvement in Clinical Measures of Obstructive Sleep Apnea

Vor 6 Jahren • 22 Aufrufe

RespireRx Pharmaceuticals Inc. Publishes Compelling Scientific Evidence Demonstrating the Neurobiological Safety of Ampakine CX717 and Justifying Continued Clinical Development

Vor 6 Jahren • 79 Aufrufe

RespireRx Pharmaceuticals Inc. - Press Release

Vor 5 Jahren • 91 Aufrufe

Press Release: RespireRx Pharmaceuticals Inc. Announces Publication of Ampakine Data

Vor 5 Jahren • 270 Aufrufe

RespireRx Pharmaceuticals Inc. Secures Clinical and Commercial Supply of Dronabinol for Obstructive Sleep Apnea with the Signing of a Development and Supply Agreement with Noramco, Inc.

Vor 5 Jahren • 77 Aufrufe

RespireRx Pharmaceuticals Inc. Executives Presenting at the International Cannabinoid Derived Pharmaceuticals Summit

Vor 5 Jahren • 175 Aufrufe

Press Release: RespireRx Pharmaceuticals Inc. Appoints James Sapirstein as Executive Vice Chairman of the Board of Directors

Vor 5 Jahren • 61 Aufrufe

RespireRx Pharmaceuticals Inc. and Impression Healthcare Limited Announce Agreement to Explore Commercialization of Dronabinol for the Treatment of Obstructive Sleep Apnea (OSA) in Australia, New Zealand and Southeast Asia

Vor 5 Jahren • 349 Aufrufe

RespireRx Pharmaceuticals Inc. Executives Participating in the 2nd Annual International Cannabinoid Derived Pharmaceuticals Summit

Vor 4 Jahren • 100 Aufrufe

NEWS: RespireRx Pharmaceuticals Inc. Announces Entry into Option Agreement to License GABA(A) Receptor Allosteric Neuromodulator

Vor 4 Jahren • 116 Aufrufe
Personal Information
Branche
Medical / Health Care / Pharmaceuticals
Webseite
www.respirerx.com
Info
RespireRx Pharmaceuticals Inc. (formerly Cortex Pharmaceuticals, Inc.) is a biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea, drug-induced respiratory depression, and other brain-mediated breathing disorders.
Tags
pennystock respirerx sleep apnea pharmaceutical investment biotechnology ampakine stocks biotech rspi cannabinoid obstructive sleep apnea dronabinol cannabis community biopharma osa investing finance opioid induced respiratory depression stock market pharma news oird business breathing disorder neurobiology cpap medical health timothy jones press release patent cbd stock tips investor drug development #biopharmaceutical $rspi cannabis spinal chord injury ampa receptors brain adhd sleep disorder bts18 biotech showcase breathing hypopnea science medicine quarterly
Mehr anzeigen